Key result
cMyBP-C phosphorylation and haploinsufficiency cut C-zone super-relaxed myosin heads by ~30%, increasing D-zone heads.
Why the study?
Contractile force is regulated by controlling available myosins in a dynamic reserve, but the size of this reserve and its modulation by cMyBP-C remained to be examined.
Effect estimate: -16.3% absolute change (95% CI -22.8 to -9.5)
Absolute Event Rate: 37.4% vs 53.7%
Changes in cMyBP-C via phosphorylation or haploinsufficiency predominantly accelerate myosin ATP turnover in the C-zone, revealing a potentially novel negative cooperative compensatory response in the D-zone of β-cardiac muscle.
Regional SRX redistribution via cMyBP-C should not yet alter practice; leaves open compensatory myosin mechanisms in human MYBPC3 cardiomyopathy.
β-cardiac myosin mediates cardiac muscle contraction within the sarcomere by binding to the thin filament in an ATP-powered reaction. This process is highly regulated on a beat-to-beat basis by calcium interactions with the thin filament, but also contractile force is highly regulated by controlling the number of myosins available, resulting in a dynamic reserve. Our goal was to examine the size of this reserve and how it is modulated by cardiac myosin binding protein-C (cMyBP-C). We used single-molecule imaging to determine myosin activity with high spatial resolution by measuring fluorescently tagged ATP molecules binding to and releasing from myosins within the cardiac sarcomere. Three myosin ATPase states were detected: the fastest species was consistent with nonspecific ATP binding to myosin's surface, and the slower two species were consistent with the previously identified DRX and SRX states. The former represents myosins in a state ready to interact with the thin filament, and the latter in a cardiac reserve state with slowed ATPase. We found the cardiac reserve was 46% across the whole sarcomere in porcine myofibrils. Subdividing into the P-, C-, and D-zones revealed the D-zone has the smallest population of reserve heads (44%). Treatment with PKA that phosphorylates cMyBP-C led to a 16% reduction of reserve in the C-zone (where cMyBP-C is found) and a 10% reduction in the P-zone, with an unexpected 15% increase in the D-zone. Interestingly, the changes in SRX myosin head distribution by PKA phosphorylation of cMyBP-C across each subsarcomeric zone mirror the changes we identified in human cardiac myofibrils isolated from a hypertrophic cardiomyopathy patient mutation (MYBPC3-c.772G>A) that exhibits cMyBP-C haploinsufficiency. These results provide novel insights into how the C-zone functions in both porcine and human β-cardiac myosin-containing thick filaments, revealing a possible compensatory change in the D-zone upon altered cMyBP-C phosphorylation and/or haploinsufficiency.
No takes yet. Share an insight, caveat, or question.
Pilagov et al. (2025) studied Hypertrophic cardiomyopathy / Thick filament regulation (n=6). PKA phosphorylation and MYBPC3-c.772G>A mutation vs. Untreated / mutation-negative control myofibrils was evaluated on Percentage of myosin heads in the super-relaxed (SRX) biochemical state in the C-zone (PKA-treated vs untreated porcine myofibrils) (-16.3% absolute change, 95% CI -22.8 to -9.5). Both PKA-induced phosphorylation of cMyBP-C and MYBPC3-c.772G>A haploinsufficiency decreased the proportion of super-relaxed myosin heads in the C-zone while causing a compensatory increase in the D-zone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: